FDA MAP
  • Home
  • Training
    • WORKSHOPS
    • WEBINARS
    • CUSTOM TRAINING
  • SERVICES
    • REGULATORY SERVICES
    • FDA AUDITING
    • QUALITY ASSURANCE
    • CLINICAL TRIAL SERVICES
  • News Releases
  • About Us
FDA’s Tip on Communicating Cybersecurity Issues to Patients: Keep it Simple
(Thursday, October 7, 2021)
When FDA, industry, or any other stakeholder (collectively called the “messengers”) become aware of any cybersecurity vulnerabilities in a medical device connected to the internet, they must inform the patients and caregivers (collectively called the “users”) in an easy to find, read and understand communication on the internet, social media, or television. This is explained with examples and anecdotes in a White Paper released by the FDA earlier this week. Although the white paper does not contain any surprises, it contains commonsense measures to address communication with patients that may be useful as a sanity checklist for developers of such communications. It is not expected or deemed practical that the messengers will communicate with patients immediately upon becoming aware of cybersecurity vulnerabilities as such issues need to be assessed for their seriousness and impact, and mitigation strategies developed before general patient communications can be released. But when released, the message must be simplified so it could be understood clearly by diverse users, discuss the specific issues, and contain recommended actions to be taken by users. The communication must be easily findable by the intended users; the messengers may use email blasts and text messages and make the information available on platforms preferred by users. For example, the white paper emphasizes the importance of the message being optimized for reading on mobile phones. The white paper provides useful advice that may not be surprising and may not be in the more formal format of an FDA Guidance Document, but still provide a valuable document that would be used by communication teams at FDA and industry to help create SOPs for patient communication specific to cybersecurity information dissemination, and all communications, in general.

Picture
AUTHOR               

 Dr. Mukesh Kumar
​ Founder & CEO, FDAMap


 Email: mkumar@fdamap.com
​ Linkedin: Mukesh Kumar, PhD, RAC
 Instagram: 
mukeshkumarrac 
                           Twitter: @FDA_MAP
                           Youtube: MukeshKumarFDAMap

​

    Newsletter Signup
    Subscribe to FDAMap Newsletter for Refreshing Outlook on Regulatory Topics

Submit

Our Services

  • Workshops
  • Webinars
  • On-Demand Webinars
  • Custom training
  • Training Subscriptions
  • Corporate Registration
  • Certification Program
  • Smart Recruitment
  • Corporate Registration - Online Workshop​

Company

  • About Us​
  • Testimonials
  • Free Resources
  • Newsletter
  • Videos (Free Tutorials)

Support

  • Contact Us
  • Terms of Service
  • Privacy Policy
  • News Archive
Consultation Service
FDA Training Company
Copyright © 2022 FDAMap.com
Use of this Web site constitutes acceptance of the FDAMap Terms of Use and Privacy Policy.